Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion type Assertion NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_head.
- NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion description "[Together, our data suggest that RET/EGFR multi-target inhibitors might be beneficial for therapy of MTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_provenance.
- NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion evidence source_evidence_literature NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_provenance.
- NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion SIO_000772 18756447 NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_provenance.
- NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion wasDerivedFrom befree-20140225 NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_provenance.
- NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_assertion wasGeneratedBy ECO_0000203 NP807893.RAqlg7gfXQX2JecAZZ73j2PRYWv2NUmtUEl-mEZt6rRSQ130_provenance.